UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita

Frontiers in immunology, 2018-07, Vol.9, p.1558-1558

2018

Link zum Volltext

Verfügbarkeit prüfen

The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice

International immunopharmacology, 2011-11, Vol.11 (11), p.1773-1779

2011

Link zum Volltext

Verfügbarkeit prüfen

Selective Sphingosine 1-Phosphate Receptor 1 Agonist Is Protective Against Ischemia/Reperfusion in Mice

Stroke (1970), 2016-12, Vol.47 (12), p.3053-3056

2016

Link zum Volltext

Verfügbarkeit prüfen

Resident Cell Chemokine Expression Serves as the Major Mechanism for Leukocyte Recruitment During Local Inflammation

The Journal of immunology (1950), 2002-12, Vol.169 (11), p.6467-6473

2002

Link zum Volltext

Verfügbarkeit prüfen

Prediction of the skin permeability of topical drugs using in silico and in vitro models

European journal of pharmaceutical sciences, 2019-08, Vol.136, p.104945-104945, Article 104945

2019

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the chloroquine‐induced mouse model of pruritus using an automated behavioural system

Experimental dermatology, 2017-11, Vol.26 (11), p.1105-1111

2017

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Biological Evaluation of 3,4-Diaryloxazolones: A New Class of Orally Active Cyclooxygenase-2 Inhibitors

Journal of medicinal chemistry, 2000-01, Vol.43 (2), p.214-223

2000

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis

Neuroscience letters, 2013-04, Vol.541, p.161-166

2013

Link zum Volltext

Verfügbarkeit prüfen

Chemokine Receptors: Attractive Targets for Drug Discovery

Annals of the New York Academy of Sciences, 2005-06, Vol.1051 (1), p.647-657

GODESSART, NURIA

2005

Link zum Volltext

Verfügbarkeit prüfen

Understanding autoimmune disease: new targets for drug discovery

Drug discovery today, 2009-10, Vol.14 (19), p.926-934

2009

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis, and Structure−Activity Relationships of Aminopyridine N-Oxides, a Novel Scaffold for the Potent and Selective Inhibition of p38 Mitogen Activated Protein Kinase

Journal of medicinal chemistry, 2009-09, Vol.52 (17), p.5531-5545

2009

Link zum Volltext

Verfügbarkeit prüfen

Biaryl analogues of teriflunomide as potent DHODH inhibitors

Bioorganic & medicinal chemistry letters, 2011-12, Vol.21 (24), p.7268-7272

2011

Link zum Volltext

Verfügbarkeit prüfen

β2-adrenoreceptors control human skin microvascular reactivity

EJD. European journal of dermatology, 2021-06, Vol.31 (3), p.326-334

2021

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic regulation of IL‐12‐dependent T cell proliferation

Journal of leukocyte biology, 2015-10, Vol.98 (4), p.601-613

2015

Link zum Volltext

Verfügbarkeit prüfen

Chemokines in autoimmune disease

Current Opinion in Immunology, 2001-12, Vol.13 (6), p.670-675

2001

Link zum Volltext

Verfügbarkeit prüfen

Discovery and Characterization of 4‘-(2-Furyl)-N-pyridin-3-yl-4,5‘-bipyrimidin-2‘-amine (LAS38096), a Potent, Selective, and Efficacious A2B Adenosine Receptor Antagonist

Journal of medicinal chemistry, 2007-05, Vol.50 (11), p.2732-2736

2007

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-1 Enhances the Ability of Cultured Human Umbilical Vein Endothelial Cells to Oxidize Linoleic Acid

The Journal of biological chemistry, 1995-07, Vol.270 (29), p.17279-17286

1995

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Biological Evaluation of 2-Phenylpyran-4-ones: A New Class of Orally Active Cyclooxygenase-2 Inhibitors

Journal of medicinal chemistry, 2004-07, Vol.47 (15), p.3874-3886

2004

Link zum Volltext

Verfügbarkeit prüfen

Differential Pharmacological Behaviour of p38 Inhibitors in Regulating the LPS-Induced TNF-α Production in Human and Rat Whole Blood In Vitro

Inflammation, 2011-04, Vol.34 (2), p.119-132

2011

Link zum Volltext

Verfügbarkeit prüfen

Rac mediates TNF-induced cytokine production via modulation of NF-κB

Molecular immunology, 2008-05, Vol.45 (9), p.2446-2454

2008

Link zum Volltext

Verfügbarkeit prüfen

Chemokine receptor antagonists: eppur si muove

Autoimmunity reviews, 2004-11, Vol.3 (7), p.576-578

Godessart, Nuria

2004

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a novel class of zwitterionic, potent, selective and orally active S1P1 direct agonists

Bioorganic & medicinal chemistry letters, 2012-12, Vol.22 (24), p.7672-7676

2012

Link zum Volltext

Verfügbarkeit prüfen

Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist

ACS medicinal chemistry letters, 2011-03, Vol.2 (3), p.213-218

2011

Link zum Volltext

Verfügbarkeit prüfen

Chemokines in autoimmunity: from pathology to therapeutics

Autoimmunity reviews, 2002-12, Vol.1 (6), p.313-320

2002

Link zum Volltext

Verfügbarkeit prüfen

The S1P1 receptor antagonist W146 induces lymphopenia in mice. Demonstration that functional antagonism of S1P1 is the mechanism of lymphopenia evoked by fingolimod-like compounds. (140.15)

The Journal of immunology (1950), 2010-04, Vol.184 (1_Supplement), p.140-140.15

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(39)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Animals
(19)
Humans
(19)
Biological And Medical Sciences
(10)
Immunology
(10)
Male
(10)
Medical Sciences
(9)
Pharmacology. Drug Treatments
(9)
Mice
(8)
Pharmacology & Pharmacy
(8)
Rats
(8)
Dermatology
(7)
Drug Discovery
(7)
Structure-Activity Relationship
(7)
Autoimmune Diseases
(5)
Bones, Joints And Connective Tissue. Antiinflammatory Agents
(5)
Cells, Cultured
(5)
Chemistry, Medicinal
(5)
Arthritis, Experimental - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita

The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice

Selective Sphingosine 1-Phosphate Receptor 1 Agonist Is Protective Against Ischemia/Reperfusion in Mice

Resident Cell Chemokine Expression Serves as the Major Mechanism for Leukocyte Recruitment During Local Inflammation

Prediction of the skin permeability of topical drugs using in silico and in vitro models

Characterization of the chloroquine‐induced mouse model of pruritus using an automated behavioural system

Synthesis and Biological Evaluation of 3,4-Diaryloxazolones: A New Class of Orally Active Cyclooxygenase-2 Inhibitors

Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis

Chemokine Receptors: Attractive Targets for Drug Discovery

Understanding autoimmune disease: new targets for drug discovery

Design, Synthesis, and Structure−Activity Relationships of Aminopyridine N-Oxides, a Novel Scaffold for the Potent and Selective Inhibition of p38 Mitogen Activated Protein Kinase

Biaryl analogues of teriflunomide as potent DHODH inhibitors

β2-adrenoreceptors control human skin microvascular reactivity

Epigenetic regulation of IL‐12‐dependent T cell proliferation

Chemokines in autoimmune disease

Discovery and Characterization of 4‘-(2-Furyl)-N-pyridin-3-yl-4,5‘-bipyrimidin-2‘-amine (LAS38096), a Potent, Selective, and Efficacious A2B Adenosine Receptor Antagonist

Interleukin-1 Enhances the Ability of Cultured Human Umbilical Vein Endothelial Cells to Oxidize Linoleic Acid

Synthesis and Biological Evaluation of 2-Phenylpyran-4-ones: A New Class of Orally Active Cyclooxygenase-2 Inhibitors

Differential Pharmacological Behaviour of p38 Inhibitors in Regulating the LPS-Induced TNF-α Production in Human and Rat Whole Blood In Vitro

Rac mediates TNF-induced cytokine production via modulation of NF-κB

Chemokine receptor antagonists: eppur si muove

Discovery of a novel class of zwitterionic, potent, selective and orally active S1P1 direct agonists

Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist

Chemokines in autoimmunity: from pathology to therapeutics

The S1P1 receptor antagonist W146 induces lymphopenia in mice. Demonstration that functional antagonism of S1P1 is the mechanism of lymphopenia evoked by fingolimod-like compounds. (140.15)

Suchergebnisse filtern